Search the Newsreel

94,900 Shares in Cemex S.A.B. de C.V. $CX Purchased by Militia Capital Management LLC

Militia Capital Management LLC acquired 94,900 shares of Cemex S.A.B. de C.V. (NYSE:CX) during the first quarter, with the stake valued at approximately $1.09 million. Other institutional investors also increased their holdings in Cemex, contributing to institutional ownership of 82.97%. The company recently reported …

GAP’s July traffic split: Guadalajara up 13.2%, Montego Bay down 26.6%

Grupo Aeroportuario del Pacífico (GAP) reported a 1.2% increase in July 2026 terminal passenger traffic compared to July 2025, reaching 5.91 million. While its 12 Mexican airports saw a 3.9% rise, with Guadalajara up 13.2%, tourist destinations like Puerto Vallarta and Los Cabos experienced …

ASUR Announces Total Passenger Traffic for July 2026

Passenger traffic increased year-on-year by 5.8% in Colombia and decreased by 4.0% in Mexico and 5.1% Puerto Rico MEXICO CITY, Aug. 5, 2026 /PRNewswire/ -- Grupo Aeroportuario del Sureste, S.A.B. de C.V.(NYSE: ASR; BMV: ASUR), ASUR, a leading international airport group with operations in …

PAC Stock 12‑Month Price Target Raised to $264.08, Implies 20% Upside

Analysts have raised the average 12-month price target for Grupo Aeroportuario Del Pacifico, S.A. B. de C.V. (PAC) stock from $261.08 to $264.08, with forecasts ranging from $225 to $285 per share. This updated target suggests a potential upside of approximately 20% based on …

CVD Equipment Corporation to Report Second Quarter 2026 Financial Results on August 12, 2026

CVD Equipment Corporation announced it will release its financial results for the second quarter ended June 30, 2026, after market close on Wednesday, August 12, 2026. The company will host a conference call to discuss these results at 5:00 p.m. (Eastern Time) on the …

LLY Stock Alert: What to Know as Eli Lilly Teams Up With CVS on Weight-Loss Drugs

Eli Lilly (LLY) stock extended gains on Wednesday after the pharmaceutical behemoth announced a new direct-to-consumer (DTC) collaboration with CVS Health (CVS). The press release said this team-up aims to improve patient access, affordability, and pharmacy support for Eli Lilly's blockbuster weight-loss treatments, Zepbound …

CVS Health Corp (CVS) (Q2 2026) Earnings Call Highlights: Strong Earnings Beat and Raised ...

This article first appeared on GuruFocus. Revenue: Over $106 billion in Q2 2026, an increase of over 7% year-over-year. Adjusted Operating Income: Approximately $5.2 billion, up 35% from the prior year quarter. Adjusted EPS: $2.58, a significant increase of over 40% year-over-year. Cash Flow …

CVS Stock Drops 5.8% as 2027 Outlook Disappoints

This article first appeared on GuruFocus. CVS Health (NYSE:CVS), a healthcare giant spanning insurance, pharmacy-benefit management and retail pharmacies, delivered another strong quarter on Wednesday, but Wall Street still hit the sell button as the stock fell 5.8% in regular trading. Adjusted earnings jumped …

CVS Health Corp Stock (CVS) Moved Down by 4.65% on Aug 5: Drivers Behind the Movement

CVS Health (CVS) stock declined by 4.65% on August 5th, primarily due to increased medical benefit ratios in its insurance division and a lowered full-year earnings guidance. The company faces ongoing challenges from elevated medical utilization rates, soft consumer spending, and reimbursement headwinds in …

Lake Street Maintains CVRx Inc(CVRX.US) With Buy Rating, Maintains Target Price $14

Lake Street has reaffirmed its Buy rating for CVRx Inc (CVRX.US) and maintained its target price at $14. This indicates a continued positive outlook from the analyst firm regarding the company's stock performance.

CVS Health Corporation Q2 2026 Earnings Call Summary

CVS Health Corporation Q2 2026 Earnings Call Summary - Moby Strategic Performance Drivers Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here. Delivered …

CVS Health Corp. stock underperforms Wednesday when compared to competitors

CVS Health Corp. (CVS) stock fell by 5.08% on Wednesday, closing at $99.12. This underperformance occurred on a mixed trading day, with the Dow Jones Industrial Average rising but the S&P 500 Index declining. This marks the second consecutive day of losses for CVS …

CVS forecasts at least $11.5B in 2026 operating cash flow as it raises adjusted EPS guidance to $7.90-$8.10

Earnings Call Insights: CVS Health (CVS) Q2 2026 MANAGEMENT VIEW * "This quarter, each of our operating segments grew earnings and delivered performance that exceeded our expectations," said (CEO, President & Chairman J. Joyner), adding, "We generated adjusted operating income of $5.2 billion and …

CVS Health Stock Is Falling Wednesday: What's Going On? - CVS Health (NYSE:CVS)

CVS Health stock experienced a significant drop on Wednesday despite reporting strong second-quarter earnings that surpassed analyst expectations and raising its full-year guidance. The decline is attributed to profit-taking after a substantial rally, and the company also announced an expanded GLP-1 weight management platform …

Morgan Stanley upgrades Grupo Aeroportuario del Pacifico stock rating on traffic outlook

CVS Health tops second-quarter estimates, raises full-year profit outlook

CVS Health tops second-quarter estimates, raises full-year profit outlook Proactive uses images sourced from Shutterstock CVS Health Corp (NYSE:CVS) reported second-quarter revenue and profit that beat Wall Street estimates on Wednesday, and raised its full-year adjusted earnings guidance, though cautious guidance pressured shares. Revenue …

International Flavors Q2 Earnings Miss Estimates, Sales Rise Y/Y

International Flavors & Fragrances Inc. IFF reported second-quarter 2026 adjusted earnings of 82 cents per share, missing the Zacks Consensus Estimate of $1.14. The company's second-quarter 2025 adjusted earnings came in at 77 cents, excluding the results from discontinued operations. Including one-time items, the …

CVS Health (CVS) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

CVS Health (CVS) reported $106.1 billion in revenue for the quarter ended June 2026, representing a year-over-year increase of 7.3%. EPS of $2.58 for the same period compares to $1.81 a year ago. The reported revenue represents a surprise of +5.91% over the Zacks …

Earnings Call: CVS Health übertrifft Prognosen für Q2 2026, Aktie fällt aber vorbörslich

(RTTNews) - CVS Health Corp. (CVS) will host a conference call at 8:00 AM ET on August 5, 2026, to discuss Q2 26 earnings results. To access the live webcast, log on to https://investors.cvshealth.com/events-and-presentations/default.aspx The views and opinions expressed herein are the views and …

How Rising Net Interest Income But Softer Earnings At CVB Financial (CVBF) Has Changed Its Investment Story

CVB Financial (CVBF) reported increased net interest income in Q2 2026 and the first half of 2026, reaching US$162.42 million and US$280.26 million respectively, but net income and diluted EPS declined. This creates a tension in its investment narrative, as the bank must balance …

Grupo Aeroportuario del Sureste, S.A. de C.V. Stock 12‑Month Price Target Cut to $368.02, Implies 33% Upside

The 12-month price target for Grupo Aeroportuario del Sureste, S.A. de C.V. (ASUR/B) stock has been cut from $370.07 to $368.02, according to estimates from 17 analysts. This updated target implies a potential upside of approximately 33% based on the August 4th closing price. …

Morgan Stanley Upgrades Grupo Aeroportuario Del Pacifico SAB De CV to Equal Weight From Underweight

Morgan Stanley has upgraded its rating for Grupo Aeroportuario Del Pacifico SAB De CV (PAC) from Underweight to Equal Weight. This change reflects a revised outlook on the company's stock performance.

CVS Health Corp earnings beat by $0.75, revenue topped estimates

CVS Health Corp (NYSE: CVS) reported strong second-quarter results, with EPS of $2.58, significantly beating the analyst estimate of $1.83. Revenue also surpassed expectations, reaching $106.1 billion against a consensus of $100.03 billion. The company provided a positive full-year 2026 EPS guidance of $7.90-$8.10, …

CVS Health Q2 26 Earnings Conference Call At 8:00 AM ET

(RTTNews) - CVS Health Corp. (CVS) will host a conference call at 8:00 AM ET on August 5, 2026, to discuss Q2 26 earnings results. To access the live webcast, log on to https://investors.cvshealth.com/events-and-presentations/default.aspx The views and opinions expressed herein are the views and …

CVS Health (NYSE:CVS) Reports Bullish Q2 CY2026

CVS Health (NYSE:CVS) Reports Bullish Q2 CY2026 Diversified healthcare company CVS Health (NYSE:CVS) reported Q2 CY2026 results exceeding the market's revenue expectations , with sales up 7.3% year on year to $106.1 billion. Its non-GAAP profit of $2.58 per share was 39.4% above analysts' …

CVS HEALTH CORPORATION REPORTS STRONG SECOND QUARTER 2026 RESULTS AND RAISES FULL-YEAR 2026 GUIDANCE

Second quarter total revenues increased to $106.1 billion, up 7.3% year-over-year Second quarter GAAP diluted EPS of $2.31 and Adjusted EPS of $2.58 Generated year-to-date cash flow from operations of $10.6 billion Raising full-year 2026 guidance: GAAP diluted EPS guidance range to $6.84 to …

Arrowstreet Capital Limited Partnership Sells 73,814 Shares of Grupo Aeroportuario Del Pacifico, S.A. de C.V. $PAC

CVD Equipment schedules 5 p.m. Q2 results call for Aug. 12

CVC Capital Partners PLC (CVCCF) (H1 2026) Earnings Call Highlights: Record Realizations and ...

This article first appeared on GuruFocus. Fee-Paying AUM: Grew 9% year-on-year to EUR153 billion. Fee-Related Revenues: Up 9% versus the first half of '25 to EUR771 million. Fee-Related Earnings: Up 11% to EUR442 million, with an FRE margin of 57%. Performance-Related Earnings: Up 15% …

US02364WAP05 Bond Risk Profile

This page provides a risk profile for the America Movil, S.A.B. de C.V. 6.125% 15-NOV-2037 bond (US02364WAP05), listed on the Luxembourg Stock Exchange. It highlights key metrics for credit risk assessment, including security level, inflation protection, and issuer rating. The platform also offers access …

CX Makes Notable Cross Below Critical Moving Average

In trading on Tuesday, shares of Cemex S.A.B. de C.V. (Symbol: CX) crossed below their 200 day moving average of $11.76, changing hands as low as $11.54 per share. Cemex S.A.B. de C.V. shares are currently trading off about 2.2% on the day. The …

CVB FINANCIAL CORP SEC Filing (Aug 4, 2026)

This article reports on a Form 144 SEC filing by CVB FINANCIAL CORP (CVBF) on August 4, 2026. The filing indicates a proposed sale of 40,000 common shares with an aggregate market value of $927,600, acquired through a restricted stock award grant in 2010. …

CVS Health earns two Gold and one Silver Stevie® Awards for Great Employers

AI Learning Academy honored for building enterprise-wide AI literacy and colleague confidence WOONSOCKET, R.I., Aug. 4, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) today announced that its AI Learning Academy earned two Golds and one Silver at the 11th Annual Stevie Awards for Great …

Grupo Aeroportuario del Sureste, S.A. de C.V. (NYSE:ASR) Given Average Recommendation of "Hold" by Analysts

Grupo Aeroportuario del Sureste (NYSE:ASR) has received an average "Hold" rating from nine analysts, with a consensus 12-month price target of $324.50. Recent analyst actions include a downgrade from JPMorgan Chase & Co. to "underweight" and upgrades to "buy" from HSBC and UBS. The …

CapsoVision Unveils AI Highlights For Capsule Endoscopy Studies Of CapsoCam Plus System

(RTTNews) - CapsoVision, Inc. (CV), a commercial-stage medical technology company, announced the launch of AI Highlights for the CapsoCam Plus system to support physician review of small bowel capsule endoscopy studies. CapsoVision focuses on developing imaging and integrated, cloud-native, AI-enabled capsule endoscopy solutions for …

Grupo Aeroportuario del Centro Norte SAB de CV (OMAB) Risk Assessment: Volatility, Financial Risk & Investment Risk

Grupo Aeroportuario del Centro Norte SAB de CV (OMAB) has a current risk assessment score of 8.40, ranking 3 out of 5 in the Transport Infrastructure industry. The company's beta is 0.60, indicating it tends to underperform during market upturns but experience smaller declines …